Determination of ReQuest™-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies

Publisher： Karger

E-ISSN： 1421-9867|71|3|145-151

ISSN： 0012-2823

Source： Digestion, Vol.71, Iss.3, 2005-06, pp. : 145-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Determination of ReQuestTM-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies

By  

Digestion, Vol. 75, Iss. 1, 2007-05 ,pp. : 55-61

Karger

Access to resources Recommend Favorite

Novel Measurement of Rapid Treatment Success with ReQuestTM: First and Sustained Symptom Relief as Outcome Parameters in Patients with Endoscopy-Negative GERD Receiving 20 mg Pantoprazole or 20 mg Esomeprazole

By  

Digestion, Vol. 75, Iss. 1, 2007-05 ,pp. : 62-68

Karger

Access to resources Recommend Favorite

Novel Measurement of Rapid Treatment Success with ReQuestTM: First and Sustained Symptom Relief as Outcome Parameters in Patients with Endoscopy-Negative GERD Receiving 20 mg Pantoprazole or 20 mg Esomeprazole

By  

Digestion, Vol. 71, Iss. 3, 2005-06 ,pp. : 152-158

Karger

Access to resources Recommend Favorite

Are Symptom-Based Diagnostic Criteria for Irritable Bowel Syndrome Useful in Clinical Practice?

By  

Digestion, Vol. 70, Iss. 4, 2005-03 ,pp. : 207-209

Karger

Access to resources Recommend Favorite

Optimizing Symptom Relief and Preventing Complications in Adults with Gastro-Oesophageal Reflux Disease

By  

Digestion, Vol. 69, Iss. 1, 2004-03 ,pp. : 9-16

Karger

Access to resources Recommend Favorite